Eplerenone May Help Prevent Heart Failure In Acute Heart Attack Patients

A new trial presented at the ACC in San Francisco suggests that the mineralocorticoid receptor agonist eplerenone Pfizer, Inspra) may help prevent the development of heart failure when given acutely in STEMI patients without preexisting heart failure.